Skip to main content
Log in

Reply: “Treatment-of-choice for Buerger’s disease (thromboangiitis obliterans): still an unresolved issue”

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Tavakoli H, Rezaii J, Esfandiari K et al (2008) Buerger’s disease: a 10-year experience in Tehran, Iran. Clin Rheumatol 27:369–371

    Article  PubMed  Google Scholar 

  2. Paraskevas KI (2008) Treatment-of-choice for Buerger’s disease (thromboangiitis obliterans): still an unresolved issue. Clin Rheumatol 27:547

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Armin Rashidi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tavakoli, H., Salimi, J. & Rashidi, A. Reply: “Treatment-of-choice for Buerger’s disease (thromboangiitis obliterans): still an unresolved issue”. Clin Rheumatol 27, 813 (2008). https://doi.org/10.1007/s10067-008-0883-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-0883-3

Keywords

Navigation